Skip to Main Content

1,311

Views

0

CrossRef citations to date

0

Altmetric

Original Articles

Results from phase 1 of the MANIFEST clinical trial to evaluate the safety and tolerability of pelabresib in patients with myeloid malignancies

Eytan M. Steina Memorial Sloan Kettering Cancer Center, New York, NY, USACorrespondence[email protected]
View further author information

,

Amir T. Fathib Leukemia Program, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USAView further author information

,

Wael A. Harbc Horizon Oncology and Research Center, Lafayette, IN, USAView further author information

,

Gozde Colakd Constellation Pharmaceuticals, Inc., a MorphoSys Company, Boston, MA, USAView further author information

,

Andrea Fuscod Constellation Pharmaceuticals, Inc., a MorphoSys Company, Boston, MA, USAView further author information

&

James K. Mangane Department of Medicine, Division of Blood and Marrow Transplantation, University of California San Diego, La Jolla, CA, USAView further author information